Total Receivables - Zeria Pharmaceutical Co Ltd (TSE:4559) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 1 987 JPY 1.95%

Updated:

Zeria Pharmaceutical Co Ltd
Total Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Zeria Pharmaceutical Co Ltd
Total Receivables Peer Comparison

4502

4568

4578

4519

4503

Company		Total Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Zeria Pharmaceutical Co Ltd TSE:4559	Total Receivables ¥21.1B	CAGR 3-Years 16%	CAGR 5-Years 7%	CAGR 10-Years 3%
	Takeda Pharmaceutical Co Ltd TSE:4502	Total Receivables ¥697.6B	CAGR 3-Years -5%	CAGR 5-Years -1%	CAGR 10-Years 5%
	Daiichi Sankyo Co Ltd TSE:4568	Total Receivables ¥454.2B	CAGR 3-Years 25%	CAGR 5-Years 2%	CAGR 10-Years 5%
	Otsuka Holdings Co Ltd TSE:4578	Total Receivables ¥489.1B	CAGR 3-Years 12%	CAGR 5-Years 5%	CAGR 10-Years 4%
	Chugai Pharmaceutical Co Ltd TSE:4519	Total Receivables ¥240.9B	CAGR 3-Years 8%	CAGR 5-Years 6%	CAGR 10-Years 6%
	Astellas Pharma Inc TSE:4503	Total Receivables ¥548B	CAGR 3-Years 15%	CAGR 5-Years 9%	CAGR 10-Years 5%

See Also

Based on the financial report for Mar 31, 2024, Zeria Pharmaceutical Co Ltd's Total Receivables amounts to 21.1B JPY.

Over the last year, the Total Receivables growth was 21%. The average annual Total Receivables growth rates for Zeria Pharmaceutical Co Ltd have been 16% over the past three years , 7% over the past five years , and 3% over the past ten years .

Join more than 142,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.